Chronic respiratory conditions including asthma and chronic obstructive pulmonary disease (COPD) are linked to high rates of morbidity and mortality. Inhaled therapy limits systemic exposure and associated adverse effects while enabling rapid and targeted medicine delivery to the lungs, which is the cornerstone of the treatment of asthma and COPD. While selecting the best course of treatment for patients, although consideration must be given to the pharmacological choices and the efficacy, safety, and dosage of the various inhaled bronchodilators and corticosteroids (ICS) which are usually used in the treatment of these diseases, choosing and developing a drug delivery system that allows us to direct e optimize the use of such molecules are equally crucial several different inhaler products can be divided into nebulizers, dry powder inhalers, soft mist inhalers, and pressurized metered dose inhalers (pMDI). Regarding the design, handling method, and inhalation technology, each category has its own unique set of fundamental features that are linked to particular benefits and drawbacks inside each category, devices can vary greatly.
Chronic respiratory conditions including asthma and chronic obstructive pulmonary disease (COPD) are linked to high rates of morbidity and mortality. Inhaled therapy limits systemic exposure and associated adverse effects while enabling rapid and targeted medicine delivery to the lungs, which is the cornerstone of the treatment of asthma and COPD. While selecting the best course of treatment for patients, although consideration must be given to the pharmacological choices and the efficacy, safety, and dosage of the various inhaled bronchodilators and corticosteroids (ICS) which are usually used in the treatment of these diseases, choosing and developing a drug delivery system that allows us to direct e optimize the use of such molecules are equally crucial several different inhaler products can be divided into nebulizers, dry powder inhalers, soft mist inhalers, and pressurized metered dose inhalers (pMDI). Regarding the design, handling method, and inhalation technology, each category has its own unique set of fundamental features that are linked to particular benefits and drawbacks inside each category, devices can vary greatly.
INHALATION THERAPY IN TREATMENT OF COPD AND ASTHMA.
ZAYED, HOSAM
2022/2023
Abstract
Chronic respiratory conditions including asthma and chronic obstructive pulmonary disease (COPD) are linked to high rates of morbidity and mortality. Inhaled therapy limits systemic exposure and associated adverse effects while enabling rapid and targeted medicine delivery to the lungs, which is the cornerstone of the treatment of asthma and COPD. While selecting the best course of treatment for patients, although consideration must be given to the pharmacological choices and the efficacy, safety, and dosage of the various inhaled bronchodilators and corticosteroids (ICS) which are usually used in the treatment of these diseases, choosing and developing a drug delivery system that allows us to direct e optimize the use of such molecules are equally crucial several different inhaler products can be divided into nebulizers, dry powder inhalers, soft mist inhalers, and pressurized metered dose inhalers (pMDI). Regarding the design, handling method, and inhalation technology, each category has its own unique set of fundamental features that are linked to particular benefits and drawbacks inside each category, devices can vary greatly.È consentito all'utente scaricare e condividere i documenti disponibili a testo pieno in UNITESI UNIPV nel rispetto della licenza Creative Commons del tipo CC BY NC ND.
Per maggiori informazioni e per verifiche sull'eventuale disponibilità del file scrivere a: unitesi@unipv.it.
https://hdl.handle.net/20.500.14239/16563